516 related articles for article (PubMed ID: 25104306)
1. Epidemiology of invasive meningococcal disease in the Netherlands, 1960-2012: an analysis of national surveillance data.
Bijlsma MW; Bekker V; Brouwer MC; Spanjaard L; van de Beek D; van der Ende A
Lancet Infect Dis; 2014 Sep; 14(9):805-12. PubMed ID: 25104306
[TBL] [Abstract][Full Text] [Related]
2. Annual report of the Australian Meningococcal Surveillance Programme, 2011.
Lahra MM; Enriquez RP
Commun Dis Intell Q Rep; 2012 Sep; 36(3):E251-62. PubMed ID: 23186236
[TBL] [Abstract][Full Text] [Related]
3. Australian Meningococcal Surveillance Programme annual report, 2015.
Lahra MM; Enriquez RP;
Commun Dis Intell Q Rep; 2016 Dec; 40(4):E503-E511. PubMed ID: 28043225
[TBL] [Abstract][Full Text] [Related]
4. Potential Coverage of the 4CMenB Vaccine against Invasive Serogroup B
Mulhall RM; Bennett D; Cunney R; Borrow R; Lucidarme J; Findlow J; Jolley KA; Bray J; Maiden MCJ; Moschioni M; Serino L; Stella M; Medini D
mSphere; 2018 Aug; 3(4):. PubMed ID: 30135218
[No Abstract] [Full Text] [Related]
5. Predicted coverage by 4CMenB vaccine against invasive meningococcal disease cases in the Netherlands.
Freudenburg-de Graaf W; Knol MJ; van der Ende A
Vaccine; 2020 Nov; 38(49):7850-7857. PubMed ID: 33097311
[TBL] [Abstract][Full Text] [Related]
6. Annual report of the Australian Meningococcal Surveillance Programme, 2003.
Commun Dis Intell Q Rep; 2004; 28(2):194-206. PubMed ID: 15460956
[TBL] [Abstract][Full Text] [Related]
7. Culture-Confirmed Invasive Meningococcal Disease in Canada, 2010 to 2014: Characterization of Serogroup B
Tsang RSW; Law DKS; De Paola R; Giuliani M; Stella M; Zhou J; Deng S; Boccadifuoco G; Giuliani MM; Serino L
mSphere; 2020 Mar; 5(2):. PubMed ID: 32132156
[TBL] [Abstract][Full Text] [Related]
8. Annual report of the Australian Meningococcal Surveillance Programme, 2007.
Tapsall J;
Commun Dis Intell Q Rep; 2008 Sep; 32(3):299-307. PubMed ID: 19062765
[TBL] [Abstract][Full Text] [Related]
9. Australian Meningococcal Surveillance Programme annual report, 2012.
Lahra MM; Enriquez RP
Commun Dis Intell Q Rep; 2013 Sep; 37(3):E224-32. PubMed ID: 24890958
[TBL] [Abstract][Full Text] [Related]
10. Australian Meningococcal Surveillance Programme annual report, 2014.
Lahra MM; Enriquez RP
Commun Dis Intell Q Rep; 2016 Jun; 40(2):E221-8. PubMed ID: 27522133
[TBL] [Abstract][Full Text] [Related]
11. Annual report of the Australian Meningococcal Surveillance Programme, 2005.
Australian Meningococcal Surveillance Programme
Commun Dis Intell Q Rep; 2006; 30(2):211-21. PubMed ID: 16841503
[TBL] [Abstract][Full Text] [Related]
12. Temporal associations between national outbreaks of meningococcal serogroup W and C disease in the Netherlands and England: an observational cohort study.
Knol MJ; Hahné SJM; Lucidarme J; Campbell H; de Melker HE; Gray SJ; Borrow R; Ladhani SN; Ramsay ME; van der Ende A
Lancet Public Health; 2017 Oct; 2(10):e473-e482. PubMed ID: 29253430
[TBL] [Abstract][Full Text] [Related]
13. A decade of herd protection after introduction of meningococcal serogroup C conjugate vaccination.
Bijlsma MW; Brouwer MC; Spanjaard L; van de Beek D; van der Ende A
Clin Infect Dis; 2014 Nov; 59(9):1216-21. PubMed ID: 25069869
[TBL] [Abstract][Full Text] [Related]
14. Changes in the Population Structure of Invasive Neisseria meningitidis in the United States After Quadrivalent Meningococcal Conjugate Vaccine Licensure.
Wang X; Shutt KA; Vuong JT; Cohn A; MacNeil J; Schmink S; Plikaytis B; Messonnier NE; Harrison LH; Clark TA; Mayer LW
J Infect Dis; 2015 Jun; 211(12):1887-94. PubMed ID: 25556253
[TBL] [Abstract][Full Text] [Related]
15. Annual report of the Australian Meningococcal Surveillance Programme, 2004.
Austarlian Meningococcal Surveillance Programme
Commun Dis Intell Q Rep; 2005; 29(2):150-9. PubMed ID: 16119763
[TBL] [Abstract][Full Text] [Related]
16. Recent epidemiological changes in meningococcal disease may be due to the displacement of serogroup A by serogroup C in Hefei City, China.
Ni JD; Jin YH; Dai B; Wang XP; Liu DQ; Chen X; Zheng Y; Ye DQ
Postgrad Med J; 2008 Feb; 84(988):87-92. PubMed ID: 18322129
[TBL] [Abstract][Full Text] [Related]
17. Annual report of the Australian Meningococcal Surveillance Programme, 2002.
Australian Meningococcal Surveillance Programme
Commun Dis Intell Q Rep; 2003; 27(2):196-208. PubMed ID: 12926735
[TBL] [Abstract][Full Text] [Related]
18. Annual report of the Australian Meningococcal Surveillance Programme, 2000.
Commun Dis Intell Q Rep; 2001 Aug; 25(3):113-21. PubMed ID: 11596711
[TBL] [Abstract][Full Text] [Related]
19. Diversity of Canadian meningococcal serogroup B isolates and estimated coverage by an investigational meningococcal serogroup B vaccine (4CMenB).
Bettinger JA; Scheifele DW; Halperin SA; Vaudry W; Findlow J; Borrow R; Medini D; Tsang R;
Vaccine; 2013 Dec; 32(1):124-30. PubMed ID: 23588089
[TBL] [Abstract][Full Text] [Related]
20. Annual report of the Australian Meningococcal Surveillance Programme, 2007--Amended.
Tapsall J;
Commun Dis Intell Q Rep; 2009 Mar; 33(1):1-9. PubMed ID: 19618762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
